These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 11117652)

  • 21. Effect of hypnotic drugs on body balance and standing steadiness.
    Mets MA; Volkerts ER; Olivier B; Verster JC
    Sleep Med Rev; 2010 Aug; 14(4):259-67. PubMed ID: 20171127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind, randomized, comparative study to evaluate the efficacy and safety of zaleplon versus zolpidem in shortening sleep latency in primary insomnia.
    Huang YS; Hsu SC; Liu SI; Chen CK
    Chang Gung Med J; 2011; 34(1):50-6. PubMed ID: 21392474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamic profile of Zaleplon, a new non-benzodiazepine hypnotic agent.
    Patat A; Paty I; Hindmarch I
    Hum Psychopharmacol; 2001 Jul; 16(5):369-392. PubMed ID: 12404558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon.
    Stone BM; Turner C; Mills SL; Paty I; Patat A; Darwish M; Danjou P
    Br J Clin Pharmacol; 2002 Feb; 53(2):196-202. PubMed ID: 11851645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term use of sedative hypnotics in older patients with insomnia.
    Ancoli-Israel S; Richardson GS; Mangano RM; Jenkins L; Hall P; Jones WS
    Sleep Med; 2005 Mar; 6(2):107-13. PubMed ID: 15716214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis.
    Dündar Y; Dodd S; Strobl J; Boland A; Dickson R; Walley T
    Hum Psychopharmacol; 2004 Jul; 19(5):305-22. PubMed ID: 15252823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zaleplon improves sleep quality in maintenance hemodialysis patients.
    Sabbatini M; Crispo A; Pisani A; Ragosta A; Cesaro A; Mirenghi F; Cianciaruso B; Federico S
    Nephron Clin Pract; 2003; 94(4):c99-103. PubMed ID: 12972720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beyond benzodiazepines: alternative pharmacologic agents for the treatment of insomnia.
    Wagner J; Wagner ML; Hening WA
    Ann Pharmacother; 1998 Jun; 32(6):680-91. PubMed ID: 9640488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinically important drug interactions with zopiclone, zolpidem and zaleplon.
    Hesse LM; von Moltke LL; Greenblatt DJ
    CNS Drugs; 2003; 17(7):513-32. PubMed ID: 12751920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zopiclone and zaleplon vs benzodiazepines in the treatment of insomnia: Canadian consensus statement.
    Montplaisir J; Hawa R; Moller H; Morin C; Fortin M; Matte J; Reinish L; Shapiro CM
    Hum Psychopharmacol; 2003 Jan; 18(1):29-38. PubMed ID: 12532313
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of insomnia.
    Kirkwood CK
    J Am Pharm Assoc (Wash); 1999; 39(5):688-96; quiz 713-4. PubMed ID: 10533351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Individualizing therapy for early, middle-of-the-night and late-night insomnia.
    Scharf MB
    Int J Clin Pract Suppl; 2001 Jan; (116):20-4. PubMed ID: 11219329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The need for flexibility in dosing of hypnotic agents.
    Doghramji K
    Sleep; 2000 Feb; 23 Suppl 1():S16-20; discussion S21-2. PubMed ID: 10755804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of chronic insomnia in elderly persons.
    Bain KT
    Am J Geriatr Pharmacother; 2006 Jun; 4(2):168-92. PubMed ID: 16860264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electroencephalographic properties of zaleplon, a non-benzodiazepine sedative/hypnotic, in rats.
    Noguchi H; Kitazumi K; Mori M; Shiba T
    J Pharmacol Sci; 2004 Mar; 94(3):246-51. PubMed ID: 15037809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Greater incidence of depression with hypnotic use than with placebo.
    Kripke DF
    BMC Psychiatry; 2007 Aug; 7():42. PubMed ID: 17711589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eszopiclone for the treatment of insomnia.
    Scharf M
    Expert Opin Pharmacother; 2006 Feb; 7(3):345-56. PubMed ID: 16448328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "A comparison of the effectiveness of two hypnotic agents for the treatment of insomnia".
    Schwartz T; Nihalani N; Virk S; Jindal S; Costello A; Muldoon R; Azhar N; Hussein J; Tirmazi S
    Int J Psychiatr Nurs Res; 2004 Aug; 10(1):1146-50. PubMed ID: 15468607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perceptual disturbances with zaleplon.
    Bhatia SC; Arora M; Bhatia SK
    Psychiatr Serv; 2001 Jan; 52(1):109-10. PubMed ID: 11141544
    [No Abstract]   [Full Text] [Related]  

  • 40. An assessment of short-acting hypnotics.
    Mendelson WB; Jain B
    Drug Saf; 1995 Oct; 13(4):257-70. PubMed ID: 8573298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.